NCT06871046View on ClinicalTrials.gov

Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With Contusions

PHASE3RecruitingINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

February 20, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Contusions
Interventions
DRUG

Esflurbiprofen Topical System (EFTS)

One EFTS is applied to the injured area over 7 days

Trial Locations (5)

53121

RECRUITING

Medical Practice Ebert, Siemensstr

RECRUITING

Medical Practice Prof. Predel, Siemensstr

RECRUITING

Medical Practice Schaale-Maas, Siemensstr

82205

RECRUITING

Medical Practice Gastl, Römerstraße

82556

RECRUITING

Medical Practice Pabst, Sportschule Puch

All Listed Sponsors
collaborator

Clinsearch GmbH

UNKNOWN

collaborator

CRM Biometrics GmbH

INDUSTRY

collaborator

SocraTec R&D GmbH

OTHER

collaborator

SocraMetrics GmbH

INDUSTRY

collaborator

HWI pharma services GmbH

INDUSTRY

lead

Teikoku Seiyaku Co., Ltd.

INDUSTRY